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Identification of Clonogenic Common
Lymphoid Progenitors in Mouse Bone Marrow
Spangrude and Scollay, 1990; Li and Johnson, 1992),
and/or lack or low-level expression of the lineage-asso-
ciated antigens such as CD4 and Mac-1 (Morrison and
Motonari Kondo, Irving L. Weissman,
and Koichi Akashi*
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Weissman, 1994).and Developmental Biology
In addition to the loss of self-renewal activity, theStanford University School of Medicine
coordinated changes of developmental potential of HSCsStanford, California 94305
might also include the irreversible restriction of one or
more lineage commitments owing to sequential activa-
tion or silencing of various genes (reviewed by CleversSummary
and Grosschedl, 1996; Shivdasani and Orkin, 1996), in-
cluding genes related to expression of various cytokineThe existence of a common lymphoid progenitor that
receptors (McKinstry, et al., 1997). The identification ofcan only give rise to T cells, B cells, and natural killer
oligopotent hematolymphoid progenitors has been diffi-(NK) cells remains controversial and constitutes an
cult, since the evaluation of differentiation potential mayimportant gap in the hematopoietic lineage maps.
be complicated by a failure to detect a differentiationHere, we report that theLin2IL-7R1Thy-12Sca-1loc-Kitlo
into particular lineages owing to the limitation of thepopulation from adult mouse bone marrow possessed
assays available. These bipotent or oligopotent hemato-a rapid lymphoid-restricted (T, B, and NK) reconstitu-
lymphoid progenitors may not reach suitable microenvi-tion capacity in vivo but completely lacked myeloid
ronments in vivo, or may undergo insufficient expansiondifferentiation potential either in vivo or in vitro. A sin-
for detection in vivo, or appear to contain variable differ-gle Lin2IL-7R1Thy-12Sca-1loc-Kitlo cell could generate
entiation potentials owing to the stochastic nature ofat least both T and B cells. These data provide direct
lineage commitment, at least in vitro (Nakahata et al.,evidence for the existence of common lymphoid pro-
1982; Suda et al., 1984). Accordingly, the evidence forgenitors in sites of early hematopoiesis.
bipotent or oligopotent progenitors should include dem-
onstration of a strict bi- or oligopotent functional ability
that cosegregates with a distinct cell population defin-Introduction
able by some markers such as surface phenotypes, and
clonal studies showing bi- or oligolineage outcomesAdult bone marrow contains hematopoietic stem cells
from single cells contained in that population.(HSCs), which can give rise to all lymphocyte popula-
It is still unclear whether T and B cell developmenttions, as well as other blood cell types (reviewed by
could or must derive from clonogenic lymphoid-restrictedThomas, 1991). In mice, it has been possible to identify
stem cells or from common lymphoid progenitorsand isolate a purified population of HSCs (for reviews,
(CLPs), or if they derive from multipotent progenitors.see Visser and Van Bekkum, 1990; Morrison et al., 1995)
The CD101CD341Lin2c-Kit2Thy-12 population in hu-
The Thy-1.1lolineage(Lin)2/loSca-11 population represents
man bone marrow gives rise to T, B, NK, and lymphoid
only z0.05% of mouse bone marrow cells, yet upon
dendritic (LD) cells, but very few (if any) myeloerythroid
transplantation, these cells can fully reconstitute all
cells; they include clonal progenitors for B, NK, and LD
blood cell elements and radioprotect lethally irradiated
cells (Galy et al., 1995), but it is unknown if the single
congenic hosts (Spangrude et al., 1988). In C57BL/Ka-
clonogenic cell of this phenotype gives rise to T cells.
Thy1.1 mice, this population contains all of the clono-
In the murine thymus, as a population, the most imma-
genic multipotent progenitors (Uchida and Weissman, ture Thy-1loCD4loCD252CD441 or Thy-1loc-Kit1 thymic
1992). A single HSC can repopulate all blood cell types
precursors can generate all T, B, NK, and LD cells (Wu
(Smith et al., 1991; Osawa et al., 1996). Mouse HSCs
et al., 1991a; Ardavin et al., 1993; Matsuzaki et al., 1993),
have been further subdivided into three populations:
and the NK1.11c-Kit1CD252CD441 cells in fetal thymus
long-term HSCs constitute z0.005%±0.01% of mouse can generate both T and NK cells (Carlyle et al., 1997).
bone marrow (Harrison and Zhong, 1992; Morrison and However, clonal analysis of the outcomes of differentia-
Weissman, 1994; Osawa et al., 1996) and can self-renew tion from these cells have not been reported. Humans
virtually for life, short-term HSC populations have a lim- with an adenosine deaminase deficiency (Fischer, 1992;
ited self-renewal capacity, while multipotent (lympho- Markert, 1994) or mice with ablations or modifications of
myeloid) progenitors do not self-renew (Morrison and specific genes such as Ikaros and the common cytokine
Weissman, 1994; Morrison et al., 1997). The three popu- receptor g chain (gc) lack all three lymphoid classes
lations of HSCs can be arranged in a lineage, according (Georgopoulos et al., 1994; Cao et al., 1995; DiSanto et
to a progressive loss of ability to self-renew. The expres- al., 1995; Ohbo et al., 1996), but absence of different
sion markers that are used for purifying these subpopu- cells by single gene mutations do not prove existence
lations within the HSCs include c-Kit (Ikuta et al., 1991; of a common progenitor (Weissman, 1994). Thus, to
Okada et al., 1991; Ikuta and Weissman, 1992), CD34 date no direct evidence of the existence of cells with a
(Osawa et al., 1996), incorporation of mitochondrial su- capacity to generate both T and B lymphocytes, but not
pravital dye Rhodamine-123 (Mulder and Visser, 1987; myeloerythroid cells, has been reported (Shortman and
Wu, 1996). We wished to test whether CLPs may exist
in sites of early lymphopoiesis at a clonal level.*To whom correspondence should be addressed.
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Figure 1. Identification of IL-7Ra1 Common Lymphoid Progenitors (CLPs) in Mouse Bone Marrow
(A) The cells that stained in the negative to low range for lineage markers (B220, CD4, CD8, CD3, Gr-1, Mac-1, and TER119) were subdivided
into IL-7Ra positive and negative fractions (left). Sca-1 and c-Kit profiles of each fraction showed the presence of Lin2IL-7R1Sca-1loc-Kitlo
cells (top center panel) and Lin2/loIL-7Ra2Sca-1hic-Kithi cells (bottom left panel). More than 90% of the Lin2IL-7R1Sca-1loc-Kitlo cells were Thy-
1.12 (top right panel), and the CLP activity was found in the Thy-1.12 fraction (data not shown). HSCs were purified from the Thy-1.1lo fraction
of Lin2/loIL-7Ra2Sca-1hic-Kithi cells (bottom right panel) (Morrison and Weissman, 1994).
(B) The surface phenotype on reanalysis of the sorted candidate CLPs (closed histogram) and HSCs (solid line) and the cell cycle status of
the CLP population by Hoechst 33342 staining; dashed lines show negative staining of whole bone marrow cells. The candidate CLPs were
Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo, and z22% of them were in S/G2/M phase of cell cycle.
Interleukin 7 acts as a nonredundant cytokine for both Results
T cell and B cell development (Peschon et al., 1994; von
Freeden-Jeffry et al., 1995) by maintaining cell survival Identification of the Lin2IL-7R1Thy-1.12
Sca-1loc-Kitlo Populationfor T cell precursors (Akashi et al., 1997; Kondo et al.,
1997; Maraskovsky et al., 1997; von Freeden-Jeffry et We sorted the bone marrow cells in C57BL/Ka-Thy1.1
mice, using IL-7Ra expression as a marker in addition toal., 1997) as well as by supporting proliferation (Namen
et al., 1988; Sudo et al., 1989) and rearrangement of conventional HSC markers including Lin, Thy1.1, Sca-1,
and c-Kit (Morrison and Weissman, 1994). Figure 1Aimmunoglobulin heavy chain (IgH) genes for B cell pre-
cursors (Corcoran et al., 1996). IL-7 exerts its effect shows expression profiles of bone marrow cells for
these markers. The majority of cells expressing IL-7Rathrough the interaction of a high affinity receptor com-
plex composed of the IL-7 receptor (IL-7R) a chain were B2201CD431IgM2 pro-B and B2201CD432IgM2
pre-B cells (Sudo et al., 1993; data not shown). Among(IL-7Ra) and the common cytokine receptor g chain (No-
guchi et al., 1993; Kondo et al., 1994). Because of the the population of cells that did not express lineage mark-
ers (Lin2), the IL-7Ra1 fraction contained a populationpivotal role of the IL-7R-mediated signals in lymphoid
development, we searched for CLPs in C57BL/Ka- of Thy-1.12Sca-1loc-Kitlo cells that made up z0.02% of
total bone marrow cells. All of these IL-7Ra1 cells ex-Thy1.1 mouse bone marrow using IL-7Ra expression as
a marker. We demonstrated a newly identified Lin2IL- pressed the gc (data not shown), indicating that they
expressed functional IL-7R complexes. The Lin2/loIL-7R1Thy-1.12Sca-1loc-Kitlo population that possessed
rapid and prominent short-term lymphoid-restricted (T, 7Ra2 fraction contained Thy-1.1loSca-1hic-Kithi cells,
which included HSC subsets (Morrison and Weissman,B, and NK cells) reconstitution activity. A clonogenic
analysis of the cells revealed that single Lin2IL-7R1Thy- 1994) (Figure 1A). Figure 1B shows a result of reanalysis
of the sorted Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo population1.12Sca-1loc-Kitlo cells could differentiate into both T
and B cells. Thus, this population represents the earliest and the Lin2/loIL-7Ra2Thy-1.1loSca-1hic-Kithi population.
The Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells had re-known lymphoid-committed progenitor in mouse bone
marrow. arranged neither immunoglobulin heavy chain (IgH) nor
Common Lymphoid Progenitors in Mouse Bone Marrow
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Figure 2. The Expression of HSA, CD43, and
CD44 in HSCs, CLPs, and Various Lymphoid
Progenitors
The definition of thymic pro-T population
used here is CD3-CD42/loCD82/loCD252c-Kit1,
andthat of either bone marrow pro-B or pre-B
population is B2201IgM2CD431 and B2201
IgM2CD432, respectively (see Experimental
Procedures). The gray filled histograms rep-
resent the expression profiles of these anti-
gens in each population. Solid lines indicate
negative stainings. Since most Lin2IL-7R1
Sca-1loc-Kitlo cells were Thy-1.12 (Figure 1),
the stainings of HSA, CD43, and CD44 for
CLPs were done for Lin2IL-7R1Sca-1loc-Kitlo
cells.
T cell receptor b (TCRb) genes determined by PCR anal- appeared in the blood. The peak level of donor-type
(Ly5.21) B cells was apparent at 4 weeks (the earliestysis (data not shown), and z22% of the cells were in
S/G2/M phase of cell cycle, indicating that considerable point of analysis) and of T cells at 4±6 weeks after injec-
tion. The percentage of both donor-derived T and B cellsfractions are cycling (Figure 1B). Figure 2 shows the
expression of heat-stable antigen (HSA; CD24), CD43, gradually decreased, indicating that their self-renewal
potential is limited. There was no particular Vb bias inand CD44, all have been used previously for identifying
either thymic pro-T cells or pro-B cells in bone marrow the donor-derived T cells; they consisted of percentages
of Vb3-, Vb6-, Vb8-, and Vb11-positive cells similar to(Hardy et al., 1991; Wu et al., 1991b). The majority of
the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells expressed a normal mice (data not shown).
In the competitive reconstitution assay, the coinjectedlow level of CD43 and a medium level of CD44. In con-
trast, both HSCs and the CD32c-Kit1CD252 earliest thy- host-type bone marrow cells contained mature lympho-
cytes as well as a variety of stages of bone marrowmic pro-T precursors (Wu et al., 1991b; Godfrey et al.,
1992; Matsuzaki et al., 1993) expressed higher levels
of CD43 and CD44. The B2201IgM2CD431 pro-B cell
population in the bone marrow could be divided into
HSA2 and HSAhi populations, the former of which corre-
sponded to the most primitive pro-B stage (pre-pro-B;
fraction A), according to the classification proposed by
Hardy et al (1991). The Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo
cells as well as HSCs and the thymic precursors ex-
pressed low levels of HSA. Accordingly, the Lin2IL-
7R1Thy-1.12Sca-1loc-Kitlo cells are distinguishable from
pro-T and pro-B populations as well as HSCs in terms
of expression profiles of these surface markers.
The Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo Cells Possess
Rapid and Prominent Lymphoid-Restricted
Reconstitution Potential
To evaluate the differentiation capacity of the the Lin2IL-
7R1Thy-1.12Sca-1loc-Kitlo cells, we competitively recon-
Figure 3. Reconstitution Potential of the Lin2IL-7R1Thy-1.12Sca-stituted lethally irradiated (920 rad) Ly5.1 mice with 2 3
1loc-Kitlo CLP Population to Lethally Irradiated Congenic Mice103 Ly5.2 congenic Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo
Sequential analysis of blood cell chimerism after competitive recon-cells and 2 3 105 Ly5.1 syngeneic bone marrow cells.
stitution with 2 3 103 CLPs (Ly5.2)and 2 3 105 syngeneic (Ly5.1) boneFigure 3 shows the serial changes of mean percentages
marrow cells. Mean percentages of donor-derived cells positive forof chimerism in blood nucleated cells after the competi-
B220 (closed circles), CD3 (open circles), Mac-1(open squares), and
tive reconstitution. All through the analysis, we detected Gr-1 (closed squares) are shown (n 5 4). The B2201 cells in blood
exclusively donor-derived T and B cells, but donor- were surface IgM1 in all sample tested. Neither Mac-1 nor Gr-1
positive cells were detectable.derived Gr-11 granulocytes or Mac-11 monocytes never
Cell
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Figure 4. Reconstitution Potential of the Lin2IL-7R1Thy-1.12Sca-
1loc-Kitlo CLP Population (Ly5.2) to Sublethally Irradiated RAG2/2
(Ly5.1) Mice
(A±C) Phenotypic analysis of nucleated blood cells 4 weeks after Figure 5. The Sequential Analysis of Numbers of T Cell and B Cell
intravenous injection of 400 candidate CLPs (Ly5.2) into sublethally Progeny from CLP and HSC Populations
irradiated (400 rad) RAG2/2 (Ly5.1) mice are shown. The number of Absolute numbers of the donor-derived CD31 T cells (A) or B2201
donor-type (Ly5.2) CD31 (A) and B2201 (B) cells reached 176 cells/ B cells (B) in the spleen of sublethally irradiated RAG-22/2 mice
ml and 130 cells/ml of blood, respectively, but Mac-11 cells (C) were injected with either 103 Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo CLPs
absent in the blood (closed circles) or 103 Lin2/loIL-7R2Sca-1hic-Kithi HSCs (open circles)
(D) CD32NK1.11 cells were also detected in the spleen of the same were shown. The highest number of CD31 progeny that was gener-
mouse 8 weeks after injection (the profile of CD32 spleen cells is ated from 103 CLPs was z 1 3 107 at 4±6 weeks, while that of B2201
shown). progeny was z1.5 3 107 at 2 weeks. Results are shown as mean
plus S.D. (error bars) from groups of 3±5 mice at each time point.
precursors including HSCs. We considered the possibil-
ity that the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells failed shown in Figure 5, 103 CLPs could generate 0.6z1.1 3
to reach suitable bone marrow microenvironments to 107 CD31 spleen T cells by 4±6 weeks and 1.4 3 107
read out myeloid outcomes because the stromal niche B2201 spleen B cells by 2 weeks. The peaks of the CD31
may be immediately occupied by host-type progenitors T and B2201 B cells that were generated from 103 CLPs
or that myeloid differentiation from this population may appeared z7±10 days earlier than similar numbers of T
be perturbed by inflammatory cytokines released from and B cells derived from 103 HSCs. The changes of
activated lymphocytes as well as damaged stromal cells blood T and B cell numbers were almost synchronized
owing to lethal-dose irradiation (Antin and Ferrara, with those in spleen T and B cells (data not shown).
1992). To exclude these possibilities, we reconstituted Neither Gr-11 nor Mac-11 myeloid progeny could be
sublethally irradiated syngeneic RAG-2-deficient (RAG2/2) detected in either blood, bone marrow, or spleen in
mice that lack T and B cells only with the candidate these experiments.
CLP population. We first injected 400 Lin2IL-7R1Thy- Figure 6 shows the sequential changes of CD4 and
1.12Sca-1loc-Kitlo cells (Ly 5.2) to sublethally irradiated CD8 profiles of the thymic progeny derived from either
(400 rad) Ly 5.1 RAG2/2 mice. Four weeks after injection, 103 CLPs or 103 HSCs in the RAG2/2 reconstitution
the mice exhibited donor-type reconstitution only for T assay. In normal thymus, immature CD42CD82 double
and B cells, but not myeloid cells (Figure 4). Interestingly, negative cells rearrange TCR genes and proliferate to
as few as 400 cells could reconstitute the number of become CD41CD81 double positive (DP) cells, the DP
blood T and B cells to 5%±20 % of levels in normal cells receive a stringent selection determined by MHC-
mice. We could also detect donor-derived CD32NK1.11 self-peptide and TCR interactions, and a minority of DP
NK cells in the spleen in all 4 mice analyzed 8 weeks cells become CD41CD82 or CD42CD81 single positive
after transplantation (Figure 4), indicating that the CLP (SP) cells (Akashi and Weissman, 1996). RAG2/2 thymo-
population can give rise to NK cells as well as to T and cytes cannot progress to the DP stage owing to the
B cells. impairment of TCR gene rearrangements. As shown in
Next, we evaluated the changes in absolute numbers Figure 6, the appearance of donor-type (Ly5.2) DP cells
of T and B progeny in the spleen in the RAG2/2 mice and SP cells was more than a week earlier in the thymus
that were reconstituted with either 103 CLP or 103 injected with 103 CLPs (upper panels) than those injected
with 103 HSCs (lower panels). Thus, the CLP populationHSC (Lin2/loIL-7R-Thy-1.1loSca-1hic-Kithi) populations. As
Common Lymphoid Progenitors in Mouse Bone Marrow
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Figure 6. The Sequential Analysis of CD4 and CD8 Profiles of the Thymic Progeny after Reconstitution of RAG2/2 (Ly 5.1) Mice with Syngeneic
(Ly5.2) 103 CLPs or 103 HSCs
The appearance of CD41CD81 DP cells and CD41CD82 or CD4-CD81 SP cells from 103 CLPs preceded those from 103 HSCs by more than
a week.
possessed a more rapid lymphoid differentiation capac- addition of recombinant human M-CSF (25 U/ml) to the
medium did not affect the frequency for B cell differenti-ity than the HSC population.
ation, and the cells did not give rise to adherent macro-
phages (data not shown).The Differentiation Potential of Lin2IL-7R1
Thy-1.12Sca-1loc-Kitlo Cells
in Limit Dilution Analysis Clonogenic Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo Cells
Can Give Rise to B, but Not to MyeloerythroidWe evaluated the lymphoid differentiation capacity of
the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells at limit dilu- Colonies in Methylcellulose Culture
We further characterized the differentiation capacity oftion, where Poisson statistics would predict that, on
average, a single cell can proliferate and differentiate the CLP population in methylcellulose culture. First, we
cultured the cells under the conditions for myeloid col-into T or B cells. We competitively reconstituted the
lethally irradiated mice with different numbers of the ony formation listed in Table 1. We have reported that
the frequency of the cells that can respond to themethyl-CLP (Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo) cells with 2 3 105
host-type bone marrow. As shown in Figure 7A, approxi- cellulose cultures containing steel factor (SLF or c-Kit
ligand), IL-3, IL-6, granulocyte/macrophage colony-mately 1 in22 cells can generate Bcells after intravenous
injection. In this experiment, we could detect donor- stimulating factor (GM-CSF) and erythropoietin were
z80% and z20%±40% in long-term HSC and short-type T cell reconstitution in only 1 out of 18 mice that
were injected with 35 CLP cells. term HSC subsets, respectively (Morrison et al., 1996).
However, the CLP (Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo)To circumvent the problem that T cell differentiation
might fail if the cells didnot home to the thymic microen- cells did not form colonies in various cultures for myeloid
colonies (Table 1).vironment, we injected the CLPs directly into the thymus
of sublethally irradiated congenic mice, as we did in It has been shown that B cell precursors in the bone
marrow could form pre-B colonies in methylcellulosesome of the original assays to define HSCs (Spangrude
et al., 1988). The frequency of cells that have the ability containing IL-7 (Suda et al., 1989). However, when we
cultured 500 CLPs in the presence of IL-7 alone, only ato respond to the thymic microenvironment was approx-
imately 1 in 21 cells (Figure 7B). CD4 and CD8 profiles few colonies were formed on day 7. These colonies
were composed of pro-B (B2201CD431IgM2) and pre-Bof the donor-derived cells show a normal distribution of
CD4 and CD8 SP cells, and DP cells (Figure 7B). (B2201CD432IgM2) cells when analyzed on day 10 (data
not shown). We considered the possibility that theseWe also checked the B cell differentiation capacity
of the CLPs on the Whitlock-Witte-type in vitro culture earlier progenitors required earlier-acting cytokines. The
addition of SLF and/or Flt-3/Flk2 ligand (FL) (Lyman et(Whitlock and Witte, 1982; Muller-Sieburg et al., 1986),
using the S17 stromal cell layers (Collins and Dorshkind, al., 1993; Hannum et al., 1994) to this culture condition
significantly increased the frequency of colony-forming1987). The CLP cells formed B2201IgM1 mature B cell±
containing colonies after 14 days (Figure 7C). The fre- cells: z20% of the CLP cells formed colonies in the
presence of IL-7, SLF, and FL on day 7 (Table 1). Thesequency of cells that can read out differentiation into B
lineage was approximately 1 in 6. Cumano et al. (1992) colonies were determined as pro-B/pre-B colonies on
day 10 (Figure 7D). When we sorted different numbersreported that the bipotent B cell/macrophage progenitor
could differentiate into adherent macrophages as well of the cells into 96-well plates with methylcellulose con-
taining IL-7, SLF, and FL, the frequency of the cellsas mature B cells in this culture condition in the presence
of macrophage colony-stimulating factor (M-CSF). The responding to this culture condition determined on day
Cell
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Figure 7. Results of Limit Dilution Analysis of the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo CLP Population
The differentiation potential of the cells was assessed by intravenous (A) and intrathymic (B) injections after 28 and 16 days, respectively, by
culture on S17 stromal layers for 14 days (C), and by culture in methylcellulose containing SLF, IL-7, and FL for 10 days (D). The upper panels
show the percentage of failure in detection of progeny from various numbers of cells under each condition. Numbers in parenthesis represent
limiting numbers. Lower panels show surface phenotypes of the progeny under each condition. The differentiation outcomes on individual
assays were determined as mature B cells in (A), all thymic T cell components in (B), mature B cells in (C), and pro-B/pre-B cells in (D). The
surface phenotyping of a colony that grew in methylcellulose (D) was analyzed on day 10.
10 by the limit dilution analysis was also approximately colonies after replating in these conditions (data not
shown).1 in 5 cells (Figure 7D).
Figure 8 shows the appearance of a day 3 colony To confirm that the cells in the day 3 colony possess
differentiation potential for mature B cells in vivo, wederived from a single Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo
cell in the limit dilution analysis. The colonies were com- picked the cells and injected them into lethally irradiated
congenic mice with 2 3 105 host-type bone marrowposed of 20±80 blastic cells. Interestingly, cells ran-
domly changed their positions in methylcellulose along cells. Four weeks after injection, B2201IgM1 mature B
cell progeny could be detected in the spleen from 16with cell divisions from day 1 to day 2, and the cells
constituting the day 3 colony were dispersed, resem- out of 18 injected mice (data not shown). Accordingly,
virtually all clonogenic CLP cells in the methylcellulosebling the blast colonies reported by Nakahata and
Ogawa (1982) that contained cells capable of self- culture can generate mature B cells, but not myeloid
cells.renewal in vitro and of generating secondary myeloid
colonies. We picked cells from the blastic day 3 colonies
and replated them into the methylcellulose culture con- Single Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo Cells
Can Give Rise to Both T and B Cellstaining SLF, IL-3, IL-6, GM-CSF, M-CSF, and erythropoi-
etin. However, we could not detect secondary myeloid For the definition of CLPs, it was important to test
Table 1. Comparison of the Differentiation Potential of CLPs and HSCs in Methylcellulose in the Presence of Cytokines
No. of Day 7 Colonies/500 cells
Cytokines Used for Myeloid Colonies Cytokines Used for Lymphoid Colonies
SLF 1 IL-3 1 IL-6 SLF 1 IL-3 1 IL-6
SLF 1 M-CSF 1 GM-CSF 1 Epo 1 M-CSF 1 Epo IL-7 SLF 1 IL-7 SLF 1 IL-7 1 FL
Cells M B M B M B M B M B M B
CLP: Lin2IL-7R1Sca-1lo 0 0 0 0 0 0 0 2 6 1 0 34 6 5 0 101 6 8
Thy-12c-Kitlo
HSC: Lin2/loIL-7R2Sca-1hi 1 6 1 0 240 6 6 0 154 6 21 0 0 0 1 6 1 0 2 6 1 0
Thy-1loc-Kithi
Different media and FCS were used for inducing either myeloid or B lymphoid colonies (see Experimental Procedures). Epo, Erythropoietin;
M, myeloid colony included CFU-Mix, CFU-GM, BFU-E, and CFU-Meg (16); B, B lymphoid colonies consisted of pro-B and pre-B cells by
phenotype. SLF alone could not stimulate colony-formation in both culture conditions.
Results are shown as mean 6 S.D. of three independent experiments.
Common Lymphoid Progenitors in Mouse Bone Marrow
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Figure 8. Colonies Derived from Single Lin2
IL-7R1Thy-1.12Sca-1loc-Kitlo Cells in Methyl-
cellulose in the Presence of IL-7, SLF, and FL
(A) The appearance of a day 3 colony that
was derived from a single CLP on an inverted
microscope and of the cells in the colony on
Giemsa staining (right bottom). The colony
has a dispersed distribution of blastic cells.
(B) The appearance of a single CLP-derived
day 7 colony. The colony is composed of
B2201IgM2CD431 pro-B and B2201IgM2
CD432 pre-B cells (see Figure 7D).
whether a single Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cell Sixteen days after injection, donor-derived T cells
could be detected in 7 out of 20 injected thymuses.could generate both T and B cells. We picked aliquots
from the individual single cell-derived day 3 colonies Representative data are shown in Figure 8. In 2 out of
the 7 thymuses that developed donor-derived T cells,that were grown in methylcellulose containing SLF, FL,
and IL-7, and injected these cells intrathymically into the cells showed normal thymic differentiation into both
CD41 and CD81 SP T cells (case 1 in Figure 9, for exam-sublethally irradiated congenic mice. In all cases, the
remaining cells in the single cell-derivedcolonies contin- ple). The donor-derived cells contained both CD31 SP
cells and CD3lo DP cells. Neither myeloid cells nor Bued to grow in methylcellulose and formed pro-B/pre-B
cell colonies (Figure 9). cells were detectable in the thymus. In the remaining 5
Figure 9. Clonal Analysis of B Cell and T Cell Progenitor Activity of the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo CLP Population
Morphology of the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells from C57BL/Ka-Thy1.1 mice (Giemsa stain, top center). Day 3 colonies grew from
individual CLP cells (cases 1 and 8) in methylcellulose in the presence of SLF, IL-7, and FL (photographs, top, left and right). The FACS plots
show the surface phenotypes of thymic progeny after intrathymic injections (I.T.) of cells picked from single CLP cell-derived colonies and
the surface phenotype of cells from the part of the colony that remained and was further cultured on the methylcellulose. Cells that were
derived from a single CLP were able to differentiate into mature T cells (case 1) or both mature T and B cells (case 8) in the injected thymuses,
and also differentiated into pro-B/pre-B cells in the methylcellulose in both cases.
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cases (case 8 in Figure 9, for example), the progeny
from a single cell consisted of B2201 B cells as well as
CD31 SP and CD3lo DP cells. The B2201 B cells were
surface IgM1 mature B cells. Myeloid cells were not
detected. These data collectively indicate that at least
some fraction of colony-forming cells in response to
SLF, IL-7, and FL retained T-lineage as well as B-lineage
differentiation potential after 3 days of the culture.
Discussion
Our data showed that the Lin2IL-7R1Thy-1.12Sca-1lo
c-Kitlo population from bone marrow has prominent T
and B cell reconstitution potential and contains CLPs
that can give rise to at least both T and B cells. This
population exhibited no or limited self-renewal activity.
The Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells could gener- Figure 10. The Proposed Differentiation Sequences from HSCs to
ate CD32NK1.11 NK cells in the spleen after in vivo Lymphoid Cells in Adult Mice
injection (Figure 4). We have also observed the develop- The HSC population including both long-term and short-term HSCs
ment of CD32NK1.11 NK cells from the Lin2IL-7R1Thy- does not express IL-7R. They might express IL-7R heterodimer im-
mediately after the commitment to lymphoid lineages and become1.12Sca-1loc-Kitlo cells in vitro after 2 weeks in culture
the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo CLPs that are able to generateon bone marrow stromal layers upon addition of IL-2
all lymphoid classes. The CLPs differentiate into pro-B cells in bone(Aguila et al., personal communication). Thus, the
marrow (BM), whereas the CLPs that successfully reach thymic
Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells likely represent a microenvironment can read out T cell differentitation. The earliest
clonogenic CLP population, though clonal studies for thymic precursor (pro-T) population might include a small fraction
NK cells as well as T and B cells have not been done. of CLPs that have just homed to the thymus and still possess differ-
entiation potential into B and NK cells (Wu et al., 1991a; MatsuzakiFigure 10 summarizes our proposal for CLPs in lymphoid
et al., 1993). IL-7R is expressed in both T cell and B cell progenitors,development sequences from HSCs.
but IL-7 plays different roles in T- and B cell development in vivo;The Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells completely
the principal role of IL-7 in T cell development is to maintain cell
lack differentiation capacity to myeloid lineages both in survival through up-regulating (at least) Bcl-2 (Akashi et al., 1997),
vivo and in vitro. First, neither Gr-11 nor Mac-11 myeloid but that in B cell development is other than maintenance of cell
cells could be detected from 1 to 24 weeks after recon- survival (Kondo et al., 1997). The principalrole of IL-7 inB lymphopoi-
esis is probably to promote rearrangement of IgH genes (Corcoranstitution in the series of in vivo reconstitution analysis,
et al., 1996). Some of lymphoid cells may be developed directly fromand 2 3 103 CLPs could not give rise to either day 8
short-term HSC or multipotent progenitors. It is still unclear that BCFU-S or donor-derived myeloid (Mac-11 or Gr-11) cells
cells can also be derived from bipotent B cell/myeloid progenitors
in bone marrow 8 days after injection (data not shown). (Cumano et al., 1992) in vivo (see Discussion).
Second, we did not detect myeloid cells, including ad-
herent macrophages, during the culture over 21 days
on S17 stromal layers in the presence or absence of the cells differentiate into morphologically determined
dendritic cellsafter 7-day culture in methylcellulose con-M-CSF (data not shown), although the HSCs and the
ªbipotentº B cell/macrophage precursors reportedly taining SLF, IL-7, TNF-a, plus IL-1b (K. A. et al., unpub-
lished data). On the other hand, the earliest thymicgive rise to both B and myeloid cells in this condition
(Cumano et al., 1992; Morrison et al., 1996). Third, al- precursors did not give rise to colonies in the methylcel-
lulose cultures containing IL-7, SLF, and/or FL (K. A. etthough HSCs formed a variety of myeloid colonies in
methylcellulose in the presence of SLF, IL-3, IL-6, GM- al., unpublished data). The surface phenotype of the
thymic precursor was different from that of the CLPCSF, and erythropoietin in our hands (Morrison et al.,
1996), the Lin2IL-7R1Thy-1.12Sca-1loc-Kitlo cells did not population in the bone marrow (Figure 2). Furthermore,
in contrast to the proven potency of the CLP cells inform myeloid colonies in the culture. The cells constitut-
ing day 3 colonies grew in the presence of IL-7, SLF our competitive reconstitution assay (e.g., the 2 3 103
cells shown in Figure 2A), 4.5 3 103 thymic precursorsand FL did not give rise to secondary myeloid colonies
in the presence of myeloid-directed cytokines in a re- from the same C57BL strain we used here gave rise to
little or no progeny after intravenous injection to lethallyplating experiment, whereas they could give rise to only
T and B cell progeny after in vivo transfer. These data irradiated congenic mice with 5 3 104 recipient-type
bone marrow cells (Wu et al., 1991a), and the injectionindicate that the differentiating potential of the CLP pop-
ulation is strictly limited to T, B, and NK lineages. Ac- of large numbers (1±3 3 104) of cells was required to
detect the B and NK cell progeny (Wu et al., 1991a;cordingly, this population represents the earliest known
stage of lymphoid development distinct from HSCs. Matsuzaki et al., 1993). Thus, the thymic precursors and
the CLP populations differ in surface phenotype, in fre-The earliest thymic precursor population could gener-
ate B, NK, and LD cells (Wu et al., 1991a; Ardavin et quency, in proven clonogenic capacity, and in their re-
spective ªburstº size. Based on these data, it is possibleal., 1993; Matsuzaki et al., 1993). The Lin2IL-7R1Thy-
1.12Sca-1loc-Kitlo CLP population likely gives rise to LD that the earliest thymic precursor population may be
heterogeneous; this population may contain rare CLPcells as well as T, B, and NK cells, because z5% of
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cells or a small number of oligopotent progenitors for showed that some of these cells retained the capacity
B, NK, and/or LD cells as well as T cell±committed pro- for T cell differentiation (Hirayama and Ogawa, 1995),
genitors. suggesting that the colony-forming cells might be pluri-
The IL-7R1 CLP cells respond to IL-7 in cultures by potent. A population of cells isolated from fetal liver
expansion, at least for several cell doublings, retaining gives rise to both B cells and macrophages from single
their lymphoid-specific differentiation capacity. Does cells in vitro (Cumano et al., 1992). However, T cell devel-
the IL-7R play a role for generating these cells from opmental potential was not tested in that study. It re-
more primitive HSC and/or progenitor cells? This seems mains unclear whether B cells actually develop from
unlikely, since the frequency of the phenotypically deter- ªbipotentº B cell/myeloid or macrophage precursors in
mined CLP population in gc-deficient mice is compara- vivo.
ble to that in normal mice (M. K. et al., unpublished Although the CLP population presented here has dis-
data). On the other hand, the gc-deficient mice showed tinct phenotypes discernible from HSCs and completely
reduced frequencies of early pro-B and pro-T cells lacks myeloid differentiation potential in a variety of
(Kondo et al., 1997). IL-7R has been shown to mediate assays both in vivo and in vitro, we should still take the
pivotal signals for promoting IgH rearrangement for B limitation of the assays into account; the CLPs may not
cell precursors (Corcoran et al., 1996) and survial for T home suitable microenvironments for myeloid differenti-
cell precursors (Akashi et al., 1997). Thus, it could be ation after intravenous injection in vivo or may be able
that the expression of functional IL-7R complexes repre- to develop myeloid cells by the application of alternate,
sents the initial cellular change in the differentiation from yet-to-be-developed in vitro assays. This warrants fur-
HSCs to CLP cells. It is important to clarify intracellular ther analyses of the cellular characteristics of this popu-
events linked to lymphoid commitment that lead to IL-7R lation, including the expression of other known or un-
expression. The expression of IL-7R may enable CLPs to known cytokine receptors and of transcription factors
respond to IL-7 in the context of local stromal microenvi- that are related to myeloid or lymphoid commitment. It
ronments to give rise to the specified lymphocyte classes is also of interest to determine the CLP population in
and subsets. fetal hematopoiesis to clarify fetal developmental pro-
The generation of T and B cells from the Lin2IL- cesses of lymphoid cells including TCR/g/d T cells (Ikuta
7R1Thy-1.12Sca-1loc-Kitlo CLP population is rapid com- et al., 1990). Kawamoto et al. (1997) reported that T/B
pared to that from HSCs (Figures 5 and 6). Accordingly, bipotent prognitors were undetectable in either the
it is reasonable to postulate that the CLP population Lin2c-Kit1Sca-11 population enriched for HSCs or the
from the bone marrow could represent a transition state Lin2c-Kit1Sca-12 progenitor fractions in fetal liver, de-
between the known HSC (IL-7Ra2) subsets (Spangrude termined by fetal thymic organ cultures of single cells
et al., 1988; Morrison and Weissman, 1994; Osawa et in the presence of SLF, IL-3, and IL-7. However, results
al., 1996) and the earliest thymic precursors (Wu et al., of lineage outcomes may reflect the bias of lineage read-
1991; Matsuzaki et al. 1993) that are IL-7Ra1 (M. K. out in the assay system they used and/or the stochastic
et al., unpublished data) (Figure 10). We have not yet nature of lineage commitment of HSCs and progenitors.
critically assessed whether the Lin2IL-7R1Thy-1.12Sca- The isolation of a distinct population that possessed
1loc-Kitlo stage is a required intermediate for lymphoid lymphoid-restricted differentiation potential in fetal liver
differentiation. In the bone marrow, Antica et al. (1994) will be a prerequisite for determining the potential role
have reported that a Lin2Thy-1loHSA1Sca-21 population of CLPs in fetal lymphopoiesis.
may be the latest precursor for generating the earliest The generation of T and B cells from the CLP popula-
thymic precursor. This population represented z0.25% tion was prominent. The injection of as few as 103 CLPs
of bone marrow cells (z10-fold more than our popula-
could considerably restore the numbers of spleen B and
tion) and retained pluripotent differentiation capacity. It
T cells in the immunodeficient RAG-22/2 mice as early
is possible that T and B cell development may occur
as 2 weeks and 4 weeks after injection, respectively.
directly from some pluripotent progenitors or HSC sub-
Accordingly, the transplantation of the CLP populationsets that induce clonogenic cells that retain the differen-
(or its human counterpart) might be able to rapidly cor-tiation capacity to myeloid cells (Antica et al., 1994;
rect the lymphoid deficiencies that are found in variousMorrison and Weissman, 1994).
immunocompromised situations. The transduction ofSeveral reports revealed a ªcloseº relationship be-
genes into HSCs is currently difficult by using retrovirustween the development of B and monocyte lineages:
vectors, because the long-term HSCs are mainly quies-Klinken et al. (1988) demonstrated that the transfec-
cent (Morrison and Weissman, 1994). Since a consider-tion of v-raf to B cell lines established from Em-myc
able fraction of CLPs is cycling and the CLPs couldtransgenic mice could convert them into macrophages
respond to defined cytokines in vitro, transduction ofthat maintained the identical rearrangement of immuno-
genes into the CLPs might be efficient, and this mightglobulin heavy chain (IgH) genes. The clonal analysis of
benefit future gene therapy targeted for lymphoid cells.human leukemias/lymphomas with B cell/myelomono-
Thus, our data provide direct evidence for the exis-cytic phenotypes (Mirro et al., 1986; Akashi et al., 1991;
tence of a mouse clonogenic CLPs in vivo. Further char-1993) supports the possible existence of B cell/myelo-
acterization of this population could help clarify eventsmonocytic bipotent progenitors, though the transforma-
in early lymphoid commitment. It is possible that a coun-tion event itself may perturb the normal differentiation
terpart population in humans may also be isolated byprocess. In normal hematopoiesis, Hirayama et al. (1992)
using IL-7R as a marker as well as CD10, CD34, c-Kit,reported that B cellscould develop from myeloid colony-
forming cells from mouse bone marrow, but they later and/or Thy-1 (Galy et al., 1995). The identification of the
Cell
670
GTGAATC-39 (Jb2.7 int). The primers for detecting IgH rearrange-human CLPs might be useful for establishing lymphoid-
ment were 59-GACTAAGCGGAGCACCACAG-39 (DQ52) and 59-restricted therapeutic approaches for various immune
CTCTCAGCCGGCTCCCTCAGGG-39 (JH4#2). The samples were de-disorders.
natured (948C, 30 s), annealed (588C, 2 min), and extended (728C, 3
min) for 35 cycles. Amplified DNA was subjected to electrophoresis
in 1.2% agarose gel.
Experimental Procedures
Mouse Strains In Vivo and In Vitro Assays to Determine
The congenic strains of mice, C57BL/Ka-Thy1.1 (Ly5.2) and C57BL/ Differentiation Potential of CLPs
Ka-Thy1.1-Ly5.1 mice were used for the reconstitution assays. The For reconstitution assays, the purified common lymphoid progeni-
strains differed only at the Ly5 allele, and this difference made it tors (CLPs) were injected into the retroorbital venous sinus of lethally
possible to easily detect donor-derived cells generated from irradiated (920 rad) congenic mice, which differed only at the Ly5
hematopoietic progenitors. C57BL/6 RAG-22/2 (Ly5.1) mice were allele, together with 2 3 105 host Ly5±type bone marrow cells. The
generated by crossing C57BL/6 RAG-22/2 (Ly5.2) mice with C57BL/ levels of donor-derived blood nucleated cells were monitored as
6-Ly5.1 mice. The C57BL/6 RAG-22/2 (Ly5.1) mice were used as described elsewhere (Morrison and Weissman, 1994). When RAG-22/2
recipients. Mice were bred and maintained in the animal care facility mice were used as recipients, purified cells were intravenously in-
at Stanford University School of Medicine and were used at 4±10 jected into RAG-22/2 mice after irradiation at 400 rad. Intrathymic
weeks of age. injection was performed by directly injecting cells into thymuses of
mice that had been irradiated (600 rad) as described previously
(Akashi and Weissman, 1996, Akashi et al., 1997).
Cell Staining and Sorting To support the formation of myeloid colonies, progenitors were
For sorting HSC and CLP populations, bone marrow cells were cultured in an alpha-Modified Eagle Medium (aMEM)±based methyl-
stained with unconjugated rat antibodies specific for lineage (Lin) cellulose media (Methocult M3100; StemCell Technologies, Vancou-
markers (CD3, KT31.1; CD4, GK1.5; CD8, 53±6.7; B220, 6B2; Mac-1, ver, Canada) that was supplemented with 30% fetal bovine serum
M1/70; Gr-1, 8C5; and TER119). Lin1 cells were partially removed (FBS), 1% bovine serum albumin, 2 mM L-glutamine, and 50 mM
with sheep anti-rat IgG-conjugated immunomagnetic beads (Dyna- 2-mercaptoethanol. Cytokines such as mouse SLF (100 ng/ml; pro-
beads M-450, Dynal A. S., Oslo, Norway), and the remaining cells vided by Immunex), mouse IL-3 (30 ng/ml; Genzyme, Cambridge,
were stained with Cy5-PE (Tricolor)-conjugated goat anti-rat IgG MA), mouse IL-6 (10 ng/ml; Genzyme), mouse GM-CSF (10 ng/ml;
polyclonal antibodies (Caltag, Burlingame,CA). After incubation with Genzyme), human M-CSF (25 U/ml; Genzyme), and human erythro-
rat IgG (Sigma, St. Louis), cells were stained with FITC-conjugated poietin (1 U/ml) were added at the start of the culture. To examine
anti-Thy-1.1 (19XE5), Texas red±conjugated anti-Sca-1 (E13-161-7) lymphoid colony formation, we used Iscove's Modified Dulbecco's
and APC-conjugated anti-c-Kit (2B8) monoclonal antibodies. IL-7Ra Medium (IMDM)±based Methocult M3630 (StemCell Technologies)
was stained with biotinylated anti-IL-7Ra antibody (A7R34) and was containing human IL-7 (10 ng/ml) supplementedwith SLF (100ng/ml)
visualized by PE-conjugated streptavidin (Caltag). For the analysis and/or human FL (20 ng/ml; Genzyme). Progenitors were also cul-
of the pre-B and pro-B populations, bone marrow cells were stained tured on irradiated (2000 rad)-S17 stromal cell layers in 96-well
with biotinylated anti-Gr-1 and TER119, PE-conjugated anti-CD43 plates with RPMI 1640 medium containing 10% FBS (Gemini Bio-
(S7) (Pharmingen), Texas red±conjugatedpolyclonal anti-mouse IgM products, Calabasas, CA), SLF (100 ng/ml), and human IL-7 (10
(Caltag), and APC-conjugated anti-c-Kit. Cells were then stained ng/ml; gift from Sanofi). All cultures were incubated at 378C in a
with Cy5-PE (RED670)±conjugated streptavidin (GIBCO BRL, Gaith- humidified chamber under 7% CO2.
ersburg, MD). For the thymic progenitor population, thymocytes
were stained with anti-CD4 and anti-CD8, followed by Texas red±
Acknowledgmentsconjugated anti-rat IgG polyclonal antibodies (Caltag). After incuba-
tion with rat IgG, cells were stained with PE-conjugated anti-CD3,
Correspondence should be addressed to K. A. (Akashi@Darwin.APC-conjugated anti-c-Kit, and biotinylated anti-CD25 antibody
Stanford.edu). We thank S.-I. Nishikawa, N. Vita, and D. Cosman for(7D4, Pharmingen). Anti-CD25 was visualized by Cy5-PE-conju-
anti-IL-7Ra antibody, recombinant human IL-7, and recombinantgated streptavidin. FITC-conjugated antibodies for HSA (CD24;
mouse SLF, respectively; L. Jerabek for capable laboratory manage-M1/69), CD43, and CD44 (IM7) were purchased from Pharmingen.
ment; L. Hidalgo and B. Lavarro for animal care; V. Braunstein forFor cell cycle analysis, cells were first incubated with 10 mg/ml
antibody preparation; S. Cheshier for cell cycle analysis; the staffHoechst 33342 (Sigma) as described previously (Morrison and
at FACS facility for instruction of flow cytometer operation; and A.Weissman, 1994). These cells were sorted or analyzed using a highly
Schlageter for critically reviewing the manuscript. This work wasmodified triple laser (488-nm argon laser, 599-nm dye laser, and UV
mainly supported by NCI grant CA42551 to I. L. W. and in part bylaser) FACS (FACS Vantage, Becton Dickinson Immunocytometry
grant of Uehara Memorial Foundation to K. A.Systems, Mountain View, CA). Progenitors were purified by sorting
and then resorting to obtain precise numbers of cells that were
essentially pure for the indicated surface marker phenotype. In the
Received September 17, 1997; revised October 20, 1997.limit dilution assays and single-cell clonogenic assays, the resort
was performed by using a carefully calibrated automatic cell deposi-
tion unit (ACDU) system (Becton Dickinson). This system deposited References
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